Debora de Jong
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Cancer-related molecular mechanisms research 17
- MicroRNA in disease regulation 11
-
- Lymphoma Diagnosis and Treatment 19
- Co-authors
- Anke van den Berg (38 shared papers)Sibrand Poppema (16 shared papers)Joost L. Kluiver (29 shared papers)Bart‐Jan Kroesen (13 shared papers)Tjasso Blokzijl (9 shared papers)Susan C. Jacobs (6 shared papers)Geert Harms (4 shared papers)Arjan Diepstra (18 shared papers)
- Journals
- Blood (6 papers)American Journal Of Pathology (4 papers)Genes Chromosomes and Cancer (3 papers)International Journal of Biological Macromolecules (2 papers)Cancers (2 papers)
- Partner nations
- NetherlandsPolandChina
In The Last Decade
Debora de Jong
51 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 1.4k
- Pathology and Forensic Medicine 403
- Molecular Biology 1.5k
- Oncology 382
- Immunology 302
Countries citing papers authored by Debora de Jong
This map shows the geographic impact of Debora de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debora de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debora de Jong more than expected).
Fields of papers citing papers by Debora de Jong
This network shows the impact of papers produced by Debora de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debora de Jong. The network helps show where Debora de Jong may publish in the future.
Co-authors
The 25 scholars most cited alongside Debora de Jong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 589 | |
| 2 | 2003 | 210 | |
| 3 | 2005 | 199 | |
| 4 | 1995 | 195 | |
| 5 | 2009 | 124 | |
| 6 | 2006 | 120 | |
| 7 | 2005 | 118 | |
| 8 | 2009 | 103 | |
| 9 | 1996 | 56 | |
| 10 | 2006 | 51 | |
| 11 | 2015 | 51 | |
| 12 | De novo acute B-cell leukemia with translocation t(14;18): an entity with a poor prognosis. | 1991 | 50 |
| 13 | 2017 | 50 | |
| 14 | 2003 | 47 | |
| 15 | 2017 | 44 | |
| 16 | 2015 | 42 | |
| 17 | 2011 | 35 | |
| 18 | 2011 | 34 | |
| 19 | 2016 | 30 | |
| 20 | 2021 | 30 |
About Debora de Jong
Debora de Jong is a scholar working on Cancer Research, Pathology and Forensic Medicine, Molecular Biology, Immunology and Oncology, having authored 51 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), Cancer-related molecular mechanisms research (17 papers), RNA Research and Splicing (13 papers), MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (8 papers), RNA modifications and cancer (8 papers), Immune Cell Function and Interaction (5 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Cancer Research (1.4k citations), Pathology and Forensic Medicine (403 citations), Molecular Biology (1.5k citations), Oncology (382 citations) and Immunology (302 citations). Debora de Jong has collaborated with scholars based in Netherlands, Poland and China. Frequent co-authors include Anke van den Berg, Sibrand Poppema, Joost L. Kluiver, Bart‐Jan Kroesen, Tjasso Blokzijl, Susan C. Jacobs, Geert Harms, Arjan Diepstra, Klaas Kok and Miriam M. F. Hulsbeek. Their work appears in journals such as Blood, American Journal Of Pathology, Genes Chromosomes and Cancer, International Journal of Biological Macromolecules and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.